Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary

Insights

Percutaneous transluminal coronary angioplasty (PTCA) sites showed significant restenosis due to atherosclerotic plaque in all patients studied. Long-term follow-up revealed no PTCA-induced lesions, suggesting plaque progression is the primary cause of restenosis.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pathology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to treat coronary artery disease.
  • Restenosis remains a significant challenge after PTCA, impacting long-term outcomes.
  • Understanding the mechanisms of restenosis is crucial for improving treatment efficacy.

Observation:

  • This study examined four male patients who underwent PTCA of the left anterior descending coronary artery and died suddenly at varying times post-procedure (early and late).
  • Histopathological analysis revealed significant narrowing (76-95%) by atherosclerotic plaque at the PTCA site in all patients.
  • One early PTCA patient exhibited coronary artery dissection; late PTCA patients showed initial lumen improvement but subsequent severe restenosis.

Findings:

  • All four patients demonstrated severe restenosis (76-95% cross-sectional area narrowing) at the PTCA site due to atherosclerotic plaque progression.
  • No PTCA-induced lesions, such as cracks, were identified histologically in the late PTCA patients.
  • Late PTCA patients experienced a decrease in transstenotic gradient and an increase in luminal diameter immediately after PTCA, which was reversed by plaque buildup.

Implications:

  • Atherosclerotic plaque progression, rather than PTCA-induced injury, appears to be the primary driver of late restenosis after PTCA.
  • These findings highlight the need for strategies to manage plaque progression post-PTCA.
  • Further research into the long-term effects of PTCA and effective anti-restenosis therapies is warranted.